Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about ATAI
Recent news which mentions ATAI
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
April 19, 2024
Tickers
ATAI
CMPS
MNMD
Tags
MNMD
CMPS
General
From
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Tickers
AGNPF
ATAI
CMND
CMPS
Tags
DRUG
IXHL
Russell Newcombe
From
Benzinga
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Tickers
ABAT
ABIO
ACOR
ADXN
Tags
ENVB
LE
AIH
From
Benzinga
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
Tickers
ALTM
ATAI
CALM
DXYZ
Tags
OWL
SIG
CALM
From
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
Tickers
ATAI
CMND
CMPS
DRUG
Tags
psilocybin therapies
SILO
MDMA Therapy
From
Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
March 29, 2024
Tickers
ATAI
CMPS
Tags
Psychedelic/Assisted Therapies
Benzinga
Earnings
From
Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
ATAI
Psychedelics
Benzinga
From
Benzinga
ATAI Stock Earnings: ATAI Life Sciences Beats EPS, Misses Revenue for Q4 2023
March 28, 2024
Tickers
ATAI
Tags
NASDAQ:ATAI
Earnings Reports
Market News
From
InvestorPlace
Recap: ATAI Life Sciences Q4 Earnings
March 28, 2024
Tickers
ATAI
Tags
Market News
ATAI
BZI/Recaps
From
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Market News
Biotech
PBM
From
Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Tickers
ATAI
BETRF
CMND
ENVB
Tags
Psychedelics Research
Market News
OPTHF
From
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
SILO
HUGE
FDA
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
CMND
Psychedelics Financing
Psychedelic Research
From
Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
February 15, 2024
Tickers
ATAI
CMND
CMPS
DRUG
Tags
Magic Mushrooms
SILO
Psychedelics
From
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
ENVB
CMPS
MNMD
From
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Benzinga
News
TSLA
From
Benzinga
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
January 12, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
VA
Penny Stocks
Market News
From
Benzinga
Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
January 09, 2024
Tickers
ATAI
CMPS
GBNH
SEEL
Tags
SEEL
Market News
ATAI
From
InvestorPlace
3 Big New Catalysts for Psychedelics Stocks in 2024
January 08, 2024
Tickers
ATAI
CMPS
Tags
ATAI
CMPS
Recent Press Releases
From
Motley Fool
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
January 07, 2024
Tickers
AMA
ATAI
CMND
CMPS
Tags
Cannabis
SEEL
DRUG
From
Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
January 06, 2024
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Benzinga
MDMA
FDA
From
Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
Tickers
ATAI
NEWS
Tags
Psychedelic/Assisted Therapies
Penny Stocks
R/MDMA
From
Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers
ATAI
GHRS
NEWS
Tags
Penny Stocks
Cannabis
Psychedelics Investing
From
Benzinga
Psychedelic Stock Gainers And Losers From January 1, 2024
January 01, 2024
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Market News
BZI/PSYCH
Cannabis
From
Benzinga
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
December 27, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
AWKNF
SEEL
Cannabis
From
Benzinga
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
December 18, 2023
Tickers
ATAI
CMND
CMPS
DRUG
Tags
Stories That Matter
Small Cap
Penny Stocks
From
Benzinga
MindMed’s stock boosted by positive data in trial of LSD as treatment for anxiety disorder
December 14, 2023
Tickers
ATAI
CMPS
MNMD
SPX
Tags
MNMD
SPX
CMPS
From
MarketWatch
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
December 11, 2023
Tickers
ATAI
BRAXF
CMND
CMPS
Tags
DRUG
John Lennon
IXHL
From
Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelic/Assisted Therapies
SEEL
TRUFF
From
Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Psychedelic/Assisted Therapies
Cannabis
AWKNF
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.